- Home
- SXTP vs BGLC Comparison
SXTP vs BGLC Comparison
Compare SXTP & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTP | BGLC |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | Malaysia |
| Employees | 3 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 4.4M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SXTP | BGLC |
|---|---|---|
| Price | $1.50 | $1.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.10 | N/A |
| AVG Volume (30 Days) | ★ 44.1K | 4.2K |
| Earning Date | 05-15-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,424,911.00 |
| Revenue This Year | $33.92 | N/A |
| Revenue Next Year | $51.35 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.34 | $1.07 |
| 52 Week High | $8.62 | $8.98 |
Technical Indicators
Market Signals| Indicator | SXTP | BGLC |
|---|---|---|
| Relative Strength Index (RSI) | 48.05 | 23.95 |
| Support Level | $1.29 | $1.07 |
| Resistance Level | $1.59 | $2.72 |
| Average True Range (ATR) | 0.10 | 0.11 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 52.38 | 3.24 |
Price Performance
Historical ComparisonAbout SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
About BGLC BioNexus Gene Lab Corp
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.